LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 58.94 | 770.25 | 5136 | 8444 | 0.6082 | 0.7319 | MN20160304_L02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 61.16 | 770.25 | 4343 | 8892 | 0.4884 | 0.6325 | MN20160304_L02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 61.16 | 770.25 | 5289 | 8892 | 0.5948 | 0.7262 | MN20160304_L02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 63.39 | 770.25 | 4568 | 9326 | 0.4898 | 0.6401 | MN20160304_L02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 63.39 | 770.25 | 5454 | 9326 | 0.5848 | 0.7230 | MN20160304_L02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 65.61 | 770.25 | 4717 | 9736 | 0.4845 | 0.6407 | MN20160304_L02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 65.61 | 770.25 | 5649 | 9736 | 0.5802 | 0.7236 | MN20160304_L02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 67.83 | 770.25 | 4844 | 10078 | 0.4806 | 0.6416 | MN20160304_L02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 67.83 | 770.25 | 5860 | 10078 | 0.5814 | 0.7280 | MN20160304_L02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 70.05 | 770.25 | 5049 | 10413 | 0.4849 | 0.6495 | MN20160304_L02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 70.05 | 770.25 | 5983 | 10413 | 0.5745 | 0.7257 | MN20160304_L02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 72.27 | 770.25 | 5221 | 10730 | 0.4865 | 0.6546 | MN20160304_L02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 72.27 | 770.25 | 6140 | 10730 | 0.5722 | 0.7267 | MN20160304_L02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 74.50 | 770.25 | 5377 | 10991 | 0.4892 | 0.6598 | MN20160304_L02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 74.50 | 770.25 | 6317 | 10991 | 0.5747 | 0.7310 | MN20160304_L02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 76.75 | 770.25 | 5605 | 11262 | 0.4977 | 0.6700 | MN20160304_L02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 76.75 | 770.25 | 6425 | 11262 | 0.5705 | 0.7300 | MN20160304_L02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 78.98 | 770.25 | 5748 | 11518 | 0.4990 | 0.6737 | MN20160304_L02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 78.98 | 770.25 | 6545 | 11518 | 0.5682 | 0.7303 | MN20160304_L02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 81.20 | 770.25 | 5862 | 11766 | 0.4982 | 0.6753 | MN20160304_L02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 81.20 | 770.25 | 6661 | 11766 | 0.5661 | 0.7306 | MN20160304_L02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 83.42 | 770.25 | 6006 | 12031 | 0.4992 | 0.6786 | MN20160304_L02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 83.42 | 770.25 | 6706 | 12031 | 0.5574 | 0.7259 | MN20160304_L02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 85.64 | 770.25 | 6149 | 12287 | 0.5004 | 0.6818 | MN20160304_L02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 85.64 | 770.25 | 6782 | 12287 | 0.5520 | 0.7236 | MN20160304_L02 | N04 |